Abstract: PO0425
Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis
Session Information
- CKD Epidemiology, Biomarkers, Predictors
October 22, 2020 | Location: On-Demand
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Authors
- Hockham, Carinna, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Bao, Lexia, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Tiku, Anushree, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Badve, Sunil, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Gallagher, Martin P., The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Jardine, Meg J., The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Jha, Vivekanand, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
- Woodward, Mark, The George Institute for Global Health, UNSW Sydney, Sydney, Australia
- Jun, Min, The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia
Background
Individual studies reporting sex-specific chronic kidney disease (CKD) prevalence in Asia have shown inconsistent sex differences in CKD prevalence. We sought to synthesise available sex-disaggregated data to better define and compare CKD prevalence in women and men in Asia.
Methods
We systematically searched the literature for observational studies of ≥500 adults reporting sex-disaggregated CKD prevalence data in Asia. We calculated the women-to-men prevalence ratio (PR) for each study and pooled these using random-effects meta-analysis. Subgroup analyses were performed to explore potential sources of heterogeneity in the PR.
Results
Sex-disaggregated CKD prevalence data were available for 12 of the 26 Asian countries (109 studies; 1,452,308 women and 1,391,995 men). Most studies (83%) came from China, Taiwan, Japan and South Korea. Sex-specific CKD prevalence estimates varied substantially between studies (median [IQR] reported prevalence was 19% [9-35%] in women and 17% [8-28%] in men). Overall, CKD prevalence was higher in women compared to men (pooled PR 1.14; 95%CI 1.07-1.21), with evidence of significant heterogeneity (I2=99%). In subgroup analyses, prevalence was higher in women among studies with a younger mean age, a higher proportion of diabetes and that defined CKD using eGFR only (Table 1). The pooled PR varied considerably by country.
Conclusion
Existing sex-disaggregated data suggest a higher overall prevalence of CKD in women compared to men in Asia. However, adequate assessment of sex differences in CKD prevalence is limited by the absence of sex-disaggregated data for a large part of the region. Standardised reporting of sex-disaggregated CKD prevalence data in Asia is needed.
Table 1 Subgroup analyses of the pooled PR.